LYMPHOMA, T-CELL

Clinical trials for LYMPHOMA, T-CELL explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, T-CELL trials appear

Sign up with your email to follow new studies for LYMPHOMA, T-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1

Personalized chemo dose could reduce side effects in lymphoma transplant patients

Disease control Ongoing

This study is testing a new, personalized way to calculate the dose of melphalan chemotherapy given to lymphoma patients before a stem cell transplant. Instead of using a standard dose based on height and weight, researchers are using a mathematical model to calculate an optimal …

Matched conditions: LYMPHOMA, T-CELL

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

LYMPHOMA, T-CELL

Get alerted when new LYMPHOMA, T-CELL trials appear

Personalized chemo dose could reduce side effects in lymphoma transplant patients